Publikationen (30) Publikationen von SILVIA PINEDA SANJUAN

2023

  1. Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer

    Frontiers in Immunology, Vol. 14

  2. Machine Learning Applied to Omics Data

    Statistical Methods at the Forefront of Biomedical Advances (Springer International Publishing), pp. 21-43

2022

  1. 336.5: Novel Drug Target Identified for Reversal of Renal Tubular Injury

    Transplantation, Vol. 106, Núm. 9S, pp. S298-S298

  2. Perturbation of ATP6V0A1 as a Driver and Druggable Target for Renal Proximal Tubular Cellular Injury in Nephropathic Cystinosis

    BioRxiv

2021

  1. A Pan-Cancer Analysis of Tumor-Infiltrating B Cell Repertoires

    Frontiers in Immunology, Vol. 12

  2. Abstract 2787: Landscape of tumor-infiltrating B and T cell repertoire in pancreatic cancer

    Cancer Research, Vol. 81, Núm. 13_Supplement, pp. 2787-2787

  3. Author Correction: Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer’s disease (Nature Aging, (2021), 1, 10, (932-947), 10.1038/s43587-021-00122-7)

    Nature Aging

  4. Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer’s disease

    Nature Aging, Vol. 1, Núm. 10, pp. 932-947

  5. Maternal and Infant Immune Repertoire Sequencing Analysis Identifies Distinct Ig and TCR Development in Term and Preterm Infants

    Journal of Immunology, Vol. 207, Núm. 10, pp. 2445-2455

  6. Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features

    Frontiers in Immunology, Vol. 12

2020

  1. Data Integration for Immunology

    Annual Review of Biomedical Data Science, Vol. 3, pp. 113-136

  2. Immunohistochemistry-based taxonomical classification of bladder cancer predicts response to neoadjuvant chemotherapy

    Cancers, Vol. 12, Núm. 7, pp. 1-13

  3. Peripheral Blood RNA Sequencing Unravels a Differential Signature of Coding and Noncoding Genes by Types of Kidney Allograft Rejection

    Kidney International Reports, Vol. 5, Núm. 10, pp. 1706-1721

2019

  1. CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis

    Bladder Cancer, Vol. 5, Núm. 2, pp. 159-169

  2. Challenges in the integration of omics and non-omics data

    Genes, Vol. 10, Núm. 3

  3. Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Corrigendum: Novel non-histocompatibility antigen mismatched variants improve the ability to predict antibody-mediated rejection risk in kidney transplant [Front Immunol, 8, (2017) (1687)] DOI: 10.3389/fimmu.2017.01687

    Frontiers in Immunology

  2. Determining Significance in the New Era for P Values

    Journal of pediatric gastroenterology and nutrition

  3. Pre-Transplant Assessment of AMR Risk by Novel Donor/Recipient Non-HLA Variants

    Transplantation, Vol. 102, Núm. Supplement 7, pp. S165

2017

  1. Integrative eQTL analysis of tumor and host omics data in individuals with bladder cancer

    Genetic Epidemiology, Vol. 41, Núm. 6, pp. 567-573